Financhill
Buy
58

INCY Quote, Financials, Valuation and Earnings

Last price:
$86.38
Seasonality move :
6.12%
Day range:
$83.41 - $84.63
52-week range:
$53.56 - $87.24
Dividend yield:
0%
P/E ratio:
19.23x
P/S ratio:
3.65x
P/B ratio:
3.96x
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
28.37%
Market cap:
$16.5B
Revenue:
$4.2B
EPS (TTM):
$4.40

Earnings Data

Next earnings date for INCY
Oct 28
2025
Most recent earnings per share
$2.04
Beat by $0.57
(Jul 29/2025)
Consensus Estimate
$1.47
(Jul 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INCY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
10/28/2025 Q3 $1.3B -- -- $1.67 --
07/29/2025 Q2 $1.2B $1.2B $2.04 $1.47 $0.57
04/29/2025 Q1 $997.6M $1.1B $0.80 $1.05 -$0.25
02/10/2025 Q4 $1.1B $1.2B $1.02 $1.55 -$0.53
10/29/2024 Q3 $1.1B $1.1B $0.54 $1.09 -$0.55
07/30/2024 Q2 $1B $1B -$2.04 $1.11 -$3.15
04/30/2024 Q1 $924.6M $880.9M $0.75 $0.83 -$0.08
02/13/2024 Q4 $1B $1B $0.89 $1.15 -$0.26
10/31/2023 Q3 -- -- $0.76 $1.07 -$0.31
08/01/2023 Q2 -- -- $0.90 $0.87 $0.03
05/02/2023 Q1 -- -- $0.10 $0.74 -$0.64
02/07/2023 Q4 -- -- $0.13 $0.57 -$0.44
11/01/2022 Q3 -- -- $0.50 $0.71 -$0.21
08/02/2022 Q2 -- -- $0.72 $0.75 -$0.03
05/03/2022 Q1 -- -- $0.17 $0.69 -$0.52
02/08/2022 Q4 -- -- $2.54 $0.87 $1.67
11/02/2021 Q3 -- -- $0.82 $0.76 $0.06
08/03/2021 Q2 -- -- $0.67 $0.74 -$0.07
05/04/2021 Q1 -- -- $0.24 $0.64 -$0.40
02/09/2021 Q4 -- -- $0.68 $0.77 -$0.09
11/05/2020 Q3 -- -- -$0.07 $0.76 -$0.83
08/04/2020 Q2 -- -- $1.32 $0.86 $0.46
05/05/2020 Q1 -- -- -$3.33 -$2.80 -$0.53
02/13/2020 Q4 -- -- $0.51 $0.58 -$0.07
10/29/2019 Q3 -- -- $0.59 $0.64 -$0.05
07/30/2019 Q2 -- -- $0.48 $0.50 -$0.02
04/30/2019 Q1 -- -- $0.47 $0.41 $0.06
02/14/2019 Q4 -- -- $0.32 $0.49 -$0.17
10/30/2018 Q3 -- -- $0.14 $0.41 -$0.27
07/31/2018 Q2 -- -- $0.24 -- --
05/01/2018 Q1 -- -- -$0.19 -- --
02/15/2018 Q4 -- -- -$0.71 -- --
10/31/2017 Q3 -- -- $0.17 -- --
08/01/2017 Q2 -- -- -$0.06 -- --
05/04/2017 Q1 -- -- -$0.96 -- --
02/14/2017 Q4 -- -- $0.05 -- --
11/01/2016 Q3 -- -- $0.19 -- --
08/09/2016 Q2 -- -- $0.18 -- --
05/09/2016 Q1 -- -- $0.12 -- --
02/11/2016 Q4 -- -- $0.29 -- --
11/03/2015 Q3 -- -- -$0.22 -- --

Incyte Corp. Earnings Questions

  • How Much did Incyte Corp. Generate in Revenue Last Quarter?

    Incyte Corp. reported $1.2B worth of top line sales in its most recent quarter.

  • Did Incyte Corp. Beat Earnings Last Quarter?

    Incyte Corp. announced earnings per share of $2.04 which represents a beat of analyst forecast a $1.47 per share.

  • Is Incyte Corp. Profitable?

    Incyte Corp. reported $1.1B that represents $5.63 per share over the last quarter.

  • What is the Analyst Consensus for Incyte Corp. EPS Next Year?

    Incyte Corp.'s earnings are forecast to grow from $0.15 per share to $1.29 per share next year representing an increase of 3974.41%.

  • When is Incyte Corp.'s Earnings Date?

    Incyte Corp.'s next earnings date is October 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is XRAY Stock Undervalued?
Is XRAY Stock Undervalued?

Dentsply Sirona (NASDAQ:XRAY) is a large manufacturer of dental equipment…

Is Clarivate Stock Undervalued?
Is Clarivate Stock Undervalued?

Clarivate (NYSE:CLVT) is an analytics and research business whose services…

Is Dick’s Sporting Goods Stock Undervalued?
Is Dick’s Sporting Goods Stock Undervalued?

The market still prices Dick’s Sporting Goods (NYSE: DKS) at…

Stock Ideas

Buy
61
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Alerts

Sell
30
MRVL alert for Sep 2

Marvell Technology, Inc. [MRVL] is down 0.36% over the past day.

Buy
62
ZEPP alert for Sep 2

Zepp Health Corp. [ZEPP] is down 1.2% over the past day.

Buy
78
AMBA alert for Sep 2

Ambarella, Inc. [AMBA] is down 7.26% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock